SARS-CoV-2 transmission risk to healthcare workers performing tracheostomies: a systematic review.


Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
07 2022
Historique:
revised: 10 05 2022
received: 03 02 2022
accepted: 14 05 2022
pubmed: 4 6 2022
medline: 13 8 2022
entrez: 3 6 2022
Statut: ppublish

Résumé

Tracheostomy is a commonly performed procedure in patients with coronavirus disease 2019 (COVID-19) receiving mechanical ventilation (MV). This review aims to investigate the occurrence of SARS-CoV-2 transmission from patients to healthcare workers (HCWs) when tracheostomies are performed. This systematic review used the preferred reporting items for systematic reviews and meta-analysis framework. Studies reporting SARS-CoV-2 infection in HCWs involved in tracheostomy procedures were included. Sixty-nine studies (between 01/11/2019 and 16/01/2022) reporting 3117 tracheostomy events were included, 45.9% (1430/3117) were performed surgically. The mean time from MV initiation to tracheostomy was 16.7 ± 7.9 days. Location of tracheostomy, personal protective equipment used, and anaesthesia technique varied between studies. The mean procedure duration was 14.1 ± 7.5 minutes; was statistically longer for percutaneous tracheostomies compared with surgical tracheostomies (mean duration 17.5 ± 7.0 versus 15.5 ± 5.6 minutes, p = 0.02). Across 5 out of 69 studies that reported 311 tracheostomies, 34 HCWs tested positive for SARS-CoV-2 and 23/34 (67.6%) were associated with percutaneous tracheostomies. In this systematic review we found that SARS-CoV-2 transmission to HCWs performing or assisting with a tracheostomy procedure appeared to be low, with all reported transmissions occurring in 2020, prior to vaccinations and more recent strains of SARS-CoV-2. Transmissions may be higher with percutaneous tracheostomies. However, an accurate estimation of infection risk was not possible in the absence of the actual number of HCWs exposed to the risk during the procedure and the inability to control for multiple confounders related to variable timing, technique, and infection control practices.

Sections du résumé

BACKGROUND
Tracheostomy is a commonly performed procedure in patients with coronavirus disease 2019 (COVID-19) receiving mechanical ventilation (MV). This review aims to investigate the occurrence of SARS-CoV-2 transmission from patients to healthcare workers (HCWs) when tracheostomies are performed.
METHODS
This systematic review used the preferred reporting items for systematic reviews and meta-analysis framework. Studies reporting SARS-CoV-2 infection in HCWs involved in tracheostomy procedures were included.
RESULTS
Sixty-nine studies (between 01/11/2019 and 16/01/2022) reporting 3117 tracheostomy events were included, 45.9% (1430/3117) were performed surgically. The mean time from MV initiation to tracheostomy was 16.7 ± 7.9 days. Location of tracheostomy, personal protective equipment used, and anaesthesia technique varied between studies. The mean procedure duration was 14.1 ± 7.5 minutes; was statistically longer for percutaneous tracheostomies compared with surgical tracheostomies (mean duration 17.5 ± 7.0 versus 15.5 ± 5.6 minutes, p = 0.02). Across 5 out of 69 studies that reported 311 tracheostomies, 34 HCWs tested positive for SARS-CoV-2 and 23/34 (67.6%) were associated with percutaneous tracheostomies.
CONCLUSIONS
In this systematic review we found that SARS-CoV-2 transmission to HCWs performing or assisting with a tracheostomy procedure appeared to be low, with all reported transmissions occurring in 2020, prior to vaccinations and more recent strains of SARS-CoV-2. Transmissions may be higher with percutaneous tracheostomies. However, an accurate estimation of infection risk was not possible in the absence of the actual number of HCWs exposed to the risk during the procedure and the inability to control for multiple confounders related to variable timing, technique, and infection control practices.

Identifiants

pubmed: 35655401
doi: 10.1111/ans.17814
pmc: PMC9347596
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1614-1625

Informations de copyright

© 2022 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.

Références

Int J Oral Maxillofac Surg. 2020 Nov;49(11):1385-1391
pubmed: 32912655
Trauma Surg Acute Care Open. 2021 Jan 19;6(1):e000591
pubmed: 34192162
J Clin Anesth. 2020 Dec;67:109977
pubmed: 32653759
Crit Care Resusc. 2020 Oct 06;:
pubmed: 33105919
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):887-888
pubmed: 32880624
BMC Public Health. 2009 Mar 13;9:81
pubmed: 19284644
BMC Infect Dis. 2017 Jul 14;17(1):498
pubmed: 28709419
J Clin Virol. 2020 Aug;129:104455
pubmed: 32485618
Chest. 2022 Jan;161(1):121-129
pubmed: 34147502
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Head Neck. 2020 Jun;42(6):1282-1290
pubmed: 32304119
Anesth Analg. 2020 Aug;131(2):e128-e130
pubmed: 32404591
Oral Oncol. 2020 Jun 17;109:104861
pubmed: 32590297
JAMA Otolaryngol Head Neck Surg. 2021 May 1;147(5):450-459
pubmed: 33704354
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66
pubmed: 33119402
Can J Surg. 2014 Dec;57(6):364-5
pubmed: 25354163
OTO Open. 2020 Sep 15;4(3):2473974X20957636
pubmed: 32974425
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
Lancet. 2021 Jun 5;397(10290):2132-2135
pubmed: 34000256
Chest. 2020 Oct;158(4):1499-1514
pubmed: 32512006
Anaesthesia. 2020 Nov;75(11):1437-1447
pubmed: 32516833
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Viruses. 2020 Dec 10;12(12):
pubmed: 33322035
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):517-518
pubmed: 32232426
Lancet Respir Med. 2020 Jul;8(7):717-725
pubmed: 32422180
J Am Coll Surg. 2011 Feb;212(2):163-70
pubmed: 21193331
Br J Anaesth. 2020 Dec;125(6):e485-e487
pubmed: 33036758
Auris Nasus Larynx. 2021 Jun;48(3):511-517
pubmed: 33143935
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Surgeon. 2021 Oct;19(5):e304-e309
pubmed: 33722466
Br J Anaesth. 2021 Mar;126(3):e122-e125
pubmed: 33390258
Br J Anaesth. 2020 Dec;125(6):867-871
pubmed: 32951840
Ann Card Anaesth. 2017 Jan;20(Supplement):S19-S25
pubmed: 28074819
J Otolaryngol Head Neck Surg. 2020 Apr 27;49(1):23
pubmed: 32340627
Br J Anaesth. 2020 Dec;125(6):872-879
pubmed: 32988602
Br J Anaesth. 2020 Dec;125(6):880-894
pubmed: 32977955
Anaesthesia. 2020 Jul;75(7):970-971
pubmed: 32275770
PLoS One. 2012;7(4):e35797
pubmed: 22563403
JAMA Surg. 2021 Sep 1;156(9):883-885
pubmed: 34019099
Infect Control Hosp Epidemiol. 2022 Feb;43(2):271-272
pubmed: 33397521
Indian J Otolaryngol Head Neck Surg. 2021 Mar 4;:1-4
pubmed: 33686367
Crit Care. 2021 Aug 31;25(1):316
pubmed: 34461964

Auteurs

Ashwin Subramaniam (A)

Department of Intensive Care Medicine, Peninsula Health, Melbourne, Victoria.
Monash University, Peninsula Clinical School, Melbourne, Victoria, Australia.
Australian and New Zealand Intensive Care Research Centre (ANZIC RC), Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Zheng Jie Lim (ZJ)

Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia.

Mallikarjuna Ponnapa Reddy (M)

Department of Intensive Care Medicine, Peninsula Health, Melbourne, Victoria.
Department of Intensive Care Medicine, Calvary Hospital, Canberra, Australian Capital Territory, Australia.

Hayden Mitchell (H)

Department of Medicine, Peninsula Health, Frankston, Victoria, Australia.

Kiran Shekar (K)

Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.
School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Institute of Health and Biomedical innovation, University of Technology Brisbane, Brisbane, Queensland, Australia.
School of Medicine, Bond University, Gold Coast, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH